Sabby Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Sabby Management’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,077,555	Closed	-$107K	–	359
2016 Q3	$107K	Buy	1,077,555 +984,272	+1,055%	+$215K	﹤0.01%	288
2016 Q2	$35K	Sell	93,283 -632,917	-87%	-$241K	﹤0.01%	279
2016 Q1	$275K	Sell	726,200 -1,129,819	-61%	-$465K	0.01%	245
2015 Q4	$724K	Sell	1,856,019 -126,118	-6%	-$59.8K	0.04%	212
2015 Q3	$1.14M	Sell	1,982,137 -1,293,792	-39%	-$663K	0.05%	219
2015 Q2	$1.77M	Buy	+3,275,929	New	+$2.67M	0.06%	179

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Sabby Management's PVCT Position: Q4 2016 in Review

Sabby Management sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 1,077,555 shares — an estimated $107K sold.

Sabby Management first reported a position in PVCT in Q2 2015 and held it in 6 quarters. The position peaked at $1.77M in Q2 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Sabby Management reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Sabby Management sold 1,077,555 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $107K.
Sabby Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2015 and held it in 6 quarters.
Sabby Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $1.77M in Q2 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.